We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYPH
401
Cypherpunk Technologies Inc
CYPH
$71.7M
– –
-105,108
Closed -$302K
MCD icon
402
McDonald's
MCD
$196B
– –
-7,500
Closed -$2.17M
MGNI icon
403
Magnite
MGNI
$3.49B
– –
-50,000
Closed -$797K
MLTX icon
404
MoonLake Immunotherapeutics
MLTX
$1.53B
– –
-20,740
Closed -$1.12M
MMM icon
405
3M
MMM
$93.2B
– –
-56,300
Closed -$7.27M
MRVL icon
406
Marvell Technology
MRVL
$189B
– –
-5,000
Closed -$552K
MSTR icon
407
Strategy Inc
MSTR
$37.2B
– –
-2,937
Closed -$851K
NBIX icon
408
Neurocrine Biosciences
NBIX
$16.2B
– –
-23,111
Closed -$3.15M
NBIX icon
409
PUT
Neurocrine Biosciences
NBIX
$16.2B
– –
-15,000
Closed -$18K
NERV icon
410
Minerva Neurosciences
NERV
$207M
– –
-107,256
Closed -$238K
NKE icon
411
PUT
Nike
NKE
$62.3B
– –
-68,000
Closed -$84K
NOW icon
412
ServiceNow
NOW
$121B
– –
-2,190
Closed -$464K
NTES icon
413
NetEase
NTES
$83.5B
– –
-36,000
Closed -$3.21M
NVO
414
PUT
Novo Nordisk
NVO
$203B
– –
-10,000
Closed -$15.2K
ON icon
415
ON Semiconductor
ON
$18.6B
– –
-27,500
Closed -$1.73M
ORCL icon
416
Oracle
ORCL
$413B
– –
-20,729
Closed -$3.45M
OVID icon
417
Ovid Therapeutics
OVID
$495M
– –
-943,416
Closed -$881K
OXY.WS icon
418
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
– –
-300,000
Closed -$8.25M
PANW icon
419
Palo Alto Networks
PANW
$293B
– –
-1,412
Closed -$257K
PCAR icon
420
PACCAR
PCAR
$69.5B
– –
-25,000
Closed -$2.6M
PD icon
421
PagerDuty
PD
$856M
– –
-22,500
Closed -$411K
PLRX icon
422
Pliant Therapeutics
PLRX
$65M
– –
-103,563
Closed -$1.36M
PRAX icon
423
CALL
Praxis Precision Medicines
PRAX
$10.3B
– –
-10,000
Closed -$41.8K
PRQR icon
424
ProQR Therapeutics
PRQR
$268M
– –
-227,020
Closed -$602K
PYXS icon
425
Pyxis Oncology
PYXS
$238M
– –
-146,400
Closed -$228K
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.